| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 0% | 0/4 |
| Female | 100% | 4/4 |
| Indifferent | 0% | 0/4 |
| Unknown | 0% | 0/4 |
| General | ||
| 25% | 1/4 | |
| 25% | 1/4 | |
| 25% | 1/4 | |
| 100% | 4/4 | |
| 25% | 1/4 | |
| 50% | 2/4 | |
| 100% | 4/4 | |
| 75% | 3/4 | |
| 50% | 2/4 | |
| Severity of intellectual disability | 0% | 0/2 |
| Neurology | ||
| 100% | 4/4 | |
| 25% | 1/4 | |
| 50% | 2/4 | |
| Facial abnormalities | ||
| 50% | 2/4 | |
| 100% | 4/4 | |
| 75% | 3/4 | |
| 100% | 4/4 | |
| Visual and hearing impairments | ||
| 25% | 1/4 | |
| 75% | 3/4 | |
| Heart | ||
| 25% | 1/4 | |
| Pulmonary | ||
| 66.7% | 2/3 | |
| Gastrointestinal | ||
| 25% | 1/4 | |
| Urogenital | ||
| 50% | 2/4 | |
| Skeleton | ||
| 100% | 4/4 | |
| Skin / Hair / Nails | ||
| 25% | 1/4 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/4 |
| Metabolic | 0% | 0/4 |
| Immune | 0% | 0/4 |
| Neoplasia | ||
| Neoplasia | 0% | 0/4 |
| Inheritance | ||
| 100% | 4/4 | |
POLR3GL